{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:41:46Z","timestamp":1790656906725,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0529400"],"award-info":[{"award-number":["2024ZD0529400"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cllc.2025.04.004","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:16:29Z","timestamp":1744150589000},"page":"370-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic Implications of Lymph Node Status in Non\u2013Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study"],"prefix":"10.1016","volume":"26","author":[{"given":"Ran","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianci","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-737X","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cllc.2025.04.004_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J Clin"},{"issue":"11","key":"10.1016\/j.cllc.2025.04.004_bib0002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11912-020-00969-w","article-title":"Striving toward improved outcomes for surgically resectable non-small cell lung cancer: the promise and challenges of neoadjuvant immunotherapy","volume":"22","author":"Gentzler","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"22","key":"10.1016\/j.cllc.2025.04.004_bib0003","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-smallcell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.cllc.2025.04.004_bib0004","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","article-title":"Nivolumab plus ipilimumab in advanced non-small cell lung cancer","volume":"381","author":"Hellmann","year":"2019","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.cllc.2025.04.004_bib0005","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.cllc.2025.04.004_bib0006","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.cllc.2025.04.004_bib0007","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cllc.2025.04.004_bib0008","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JS9.0000000000000774","article-title":"Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study","volume":"110","author":"Deng","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.cllc.2025.04.004_bib0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2022.01.019","article-title":"Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer","volume":"165","author":"Wu","year":"2022","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.cllc.2025.04.004_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40164-023-00401-6","article-title":"Major pathologic response\" in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy","volume":"12","author":"Deng","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.cllc.2025.04.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107401","article-title":"Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"186","author":"Huang","year":"2023","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.cllc.2025.04.004_bib0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The eighth edition lung cancer stage classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.cllc.2025.04.004_bib0013","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1097\/JS9.0000000000000496","article-title":"Does major pathological response after neoadjuvant Immunotherapy in resectable nonsmall-cell lung cancers predict prognosis? A systematic review and meta-analysis","volume":"109","author":"Che","year":"2023","journal-title":"Int J Surg"},{"issue":"7","key":"10.1016\/j.cllc.2025.04.004_bib0014","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11605-019-04317-7","article-title":"Nodal downstaging of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: survival analysis if ypN0 is achieved","volume":"24","author":"Tang","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.cllc.2025.04.004_bib0015","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1245\/s10434-018-6471-0","article-title":"Nodal downstaging in gastric cancer patients: promising survival if ypN0 is achieved","volume":"25","author":"Ikoma","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.cllc.2025.04.004_bib0016","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cllc.2025.04.004_bib0017","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1038\/s41467-022-31941-w","article-title":"Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC","volume":"13","author":"Saddawi-Konefka","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.cllc.2025.04.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005160","article-title":"Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis","volume":"10","author":"Zhai","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.cllc.2025.04.004_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jitc-2020-002230","article-title":"Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer","volume":"9","author":"Moutafi","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.cllc.2025.04.004_bib0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41379-021-00903-w","article-title":"Heterogeneity of programmed death-ligand 1 expression and infiltrating lymphocytes in paired resected primary and metastatic non-small cell lung cancer","volume":"35","author":"Wu","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.cllc.2025.04.004_bib0021","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ejcts\/ezaa290","article-title":"Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy","volume":"59","author":"Corsini","year":"2021","journal-title":"Eur J Cardio-Thorac"},{"key":"10.1016\/j.cllc.2025.04.004_bib0022","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1200\/JCO.2020.38.15_suppl.9031","article-title":"CT and PET radiomic features associated with major pathologic response to neoadjuvant immunotherapy in early-stage non-small cell lung cancer (NSCLC)","volume":"38","author":"Nakajima","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2025.04.004_bib0023","article-title":"Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"25","key":"10.1016\/j.cllc.2025.04.004_bib0024","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.21.02660","article-title":"Overall survival and biomarker analysis of neoadjuvant nivolumab plus chemotherapy in operable stage IIIA non-small-cell lung cancer (NADIM phase II trial)","volume":"40","author":"Provencio","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:29:48Z","timestamp":1777793388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730425000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1525730425000622"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2025.04.004","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Implications of Lymph Node Status in Non\u2013Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2025.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}